跳至主要内容
临床试验/NCT03230877
NCT03230877已完成不适用

The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea

Fisher and Paykel Healthcare1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2017年9月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
38
试验地点
1
主要终点
Trial Mask Seal Acceptability

研究概览

简要总结

The investigation is a prospective, randomized, single blinded, crossover study. The investigation is designed to evaluate the performance, comfort and ease of use of the F&P Trial Full Face Mask Seal amongst Obstructive Sleep Apnea (OSA) participants. A total number of 40-45 OSA participants will be recruited for the trial by the investigation site

详细描述

This study will involve three visits to the investigation site. During visit one participants will be randomized to, fitted with and issued with the first trial mask seal for use in- home for 7 ±4 days.

The participants will then come in to return the mask seal and be fitted and issued with the second trial seal for use in home for 7±4 days.

Visit Three will involve the participants returning the second trial seal and providing feedback.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult (22+ years of age)
  • •Able to give informed consent
  • •Apnea hypopnea Index (AHI) ≥ 5 on diagnostic night
  • •Either prescribed Automatic positive airway pressure (APAP), Continuous positive airway pressure (CPAP) or Bi-level positive airway pressure (PAP) for OSA
  • •Fluent in spoken and written English
  • •Existing F&P full face mask user

排除标准

  • •Inability to give informed consent
  • •Participant intolerant to PAP
  • •Anatomical or physiological conditions making PAP therapy inappropriate
  • •Current diagnosis of respiratory disease or carbon Dioxide (CO2) retention
  • •Pregnant or may think they are pregnant.

研究组 & 干预措施

Group A

Experimental

Participants will be randomized to receive either the "Improved Seal" or "Normal Seal" Toffee full face mask for a total of 7 ± 4 days from visit 1. At visit 2 they will return the first mask and be switched to the remaining mask for a total of 7 ± 4 days from visit 2.

干预措施: Toffee full face mask with 'Improved Seal' (Device)

Group A

Experimental

Participants will be randomized to receive either the "Improved Seal" or "Normal Seal" Toffee full face mask for a total of 7 ± 4 days from visit 1. At visit 2 they will return the first mask and be switched to the remaining mask for a total of 7 ± 4 days from visit 2.

干预措施: Toffee full face mask with 'Normal Seal' (Device)

Group B

Experimental

Participants will be randomized to receive either the "Improved Seal" or "Normal Seal" Toffee full face mask for a total of 7 ± 4 days from visit 1. At visit 2 they will return the first mask and be switched to the remaining mask for a total of 7 ± 4 days from visit 2.

干预措施: Toffee full face mask with 'Improved Seal' (Device)

Group B

Experimental

Participants will be randomized to receive either the "Improved Seal" or "Normal Seal" Toffee full face mask for a total of 7 ± 4 days from visit 1. At visit 2 they will return the first mask and be switched to the remaining mask for a total of 7 ± 4 days from visit 2.

干预措施: Toffee full face mask with 'Normal Seal' (Device)

结局指标

主要结局

Trial Mask Seal Acceptability

时间窗: 14 ± 4 days in-home

Preference for trial mask determined from questionnaires at the end of the trial - Subjective

Trial Mask Seal Comfort

时间窗: 7 ± 4 days in-home

Overall seal comfort determined from questionnaires- Subjective

次要结局

  • Trial Mask Seal Usability(1 hour day-time appointment)
  • Trial Mask Seal Treatment Performance - Objective(7 ± 4 days in-home)
  • Trial Mask Seal Treatment Performance- Subjective(7 ± 4 days in-home)

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验